Efficacy and safety of regorafenib as third-line therapy in metastatic colorectal cancer: An indirect meta-analysis

Wu, YY; Fan, YW; Dong, DF; Dong, XY; Hu, Y; Shi, Y; Jing, JY; Li, EX

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):